For: |
Ni JY, Xu LF, Wang WD, Sun HL, Chen YT. Conventional transarterial chemoembolization |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i45/17206.htm |
Number | Citing Articles |
1 |
Andrew L Lewis, Sean L Willis, Matthew R Dreher, Yiqing Tang, Koorosh Ashrafi, Bradford J Wood, Elliot B Levy, Karun V Sharma, Ayele H Negussie, Andrew S Mikhail. Bench-To-Clinic Development of Imageable Drug-Eluting Embolization Beads: Finding the Balance. Future Oncology 2018; 14(26): 2741 doi: 10.2217/fon-2018-0196
|
2 |
Jun Luo, Jiaping Zheng, Changsheng Shi, Jian Fang, Zhiyi Peng, Jing Huang, Junhui Sun, Guanhui Zhou, Tiefeng Li, Dedong Zhu, Huanhai Xu, Qinming Hou, Shihong Ying, Zhichao Sun, Haijun Du, Xiaoxi Xie, Guohong Cao, Wenbin Ji, Jun Han, Wenjiang Gu, Xiaohua Guo, Guoliang Shao, Zhihai Yu, Jian Zhou, Wenqiang Yu, Xin Zhang, Ling Li, Hongjie Hu, Tingyang Hu, Xia Wu, Yutang Chen, Jiansong Ji, Wenhao Hu. Drug-eluting beads transarterial chemoembolization by CalliSpheres is effective and well tolerated in treating intrahepatic cholangiocarcinoma patients. Medicine 2020; 99(12): e19276 doi: 10.1097/MD.0000000000019276
|
3 |
Mario Angelico. TACE vs DEB-TACE: Who wins?. Digestive and Liver Disease 2016; 48(7): 796 doi: 10.1016/j.dld.2016.05.009
|
4 |
Justin Hartke, Matthew Johnson, Marwan Ghabril. The diagnosis and treatment of hepatocellular carcinoma. Seminars in Diagnostic Pathology 2017; 34(2): 153 doi: 10.1053/j.semdp.2016.12.011
|
5 |
Ning Peng, Linfeng Mao, Yiwen Tao, Kaiyin Xiao, Guandou Yuan, Songqing He. Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02717-9
|
6 |
Janesh Lakhoo, Ryan Adams, Atman Dave, Lin Luo, Christopher J. Vargo, Ari J. Isaacson, Alex Sher, Aaron Fischman, Dominic Carl Yee, Samantha Ryan, Shreejal Patel, Debora Duchac, Daniel B. Brown. Radiopaque beads loaded with doxorubicin in the treatment of patients with hepatocellular carcinoma: A retrospective, multi-center study. Cancer Treatment and Research Communications 2020; 25: 100208 doi: 10.1016/j.ctarc.2020.100208
|
7 |
Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059
|
8 |
Sihan Chen, Rengbin Ji, Xiaojun Shi, Zhe Wang, Dedong Zhu. Retrospective analysis of efficacy, safety, and prognostic factors in a cohort of Chinese hepatocellular carcinoma patients treated with drug-eluting bead transarterial chemoembolization. Brazilian Journal of Medical and Biological Research 2019; 52(12) doi: 10.1590/1414-431x20198467
|
9 |
Xuhua Duan, Juanfang Liu, Xinwei Han, Jianzhuang Ren, Hao Li, Fengyao Li, Shuguang Ju. Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres® Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.793581
|
10 |
X. Zhang, J. Zhou, D.-D. Zhu, J. Huang, J.-H. Sun, T.-F. Li, C.-S. Shi, Z.-C. Sun, Q.-M. Hou, Z.-Y. Peng, W.-Q. Yu, J.-S. Ji, W.-J. Gu, G.-H. Zhou, X.-X Xie, X.-H. Guo, G.-H. Cao, Z.-H. Yu, H.-H. Xu, J. Fang, S.-H. Ying, W.-H. Hu, W.-B. Ji, J. Han, X. Wu, J.-P. Zheng, J. Luo, Y.-T. Chen, T.-Y. Hu, L. Li, H.-J. Hu, H.-J. Du, G.-L. Shao. CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study. Clinical and Translational Oncology 2019; 21(2): 167 doi: 10.1007/s12094-018-1902-8
|
11 |
Zhongxing Shi, Dongqing Wang, Tanrong Kang, Ru Yi, Liming Cui, Huijie Jiang. Comparison of CalliSpheres® microspheres drug-eluting beads and conventional transarterial chemoembolization in hepatocellular carcinoma patients: a randomized controlled trial. Radiology and Oncology 2023; 57(1): 70 doi: 10.2478/raon-2023-0001
|
12 |
Ping Wen, Sheng-Duo Chen, Jia-Rui Wang, Ying-He Zeng. Comparison of Treatment Response and Survival Profiles Between Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Chinese Hepatocellular Carcinoma Patients: A Prospective Cohort Study. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2019; 27(5): 583 doi: 10.3727/096504018X15368325811545
|
13 |
Biao Yang, Jie Liang, ZiYu Qu, FangYun Yang, ZhengYin Liao, HongFeng Gou, Gianfranco D. Alpini. Transarterial strategies for the treatment of unresectable hepatocellular carcinoma: A systematic review. PLOS ONE 2020; 15(2): e0227475 doi: 10.1371/journal.pone.0227475
|
14 |
Andrei Florin Bloj, Ioana Hălmaciu, Bogdan Andrei Suciu, Lucian Mărginean. Treatment of Hepatocellular Carcinomas by Hepatic Transarterial Chemoembolization, Case Presentation and Review of the Literature. Acta Medica Transilvanica 2020; 25(3): 32 doi: 10.2478/amtsb-2020-0046
|
15 |
Tianshi Lyu, Jian Wang, Xiaoqiang Tong, Tianai Mi, Chao An, Yinghua Zou. Efficacy and safety of CalliSpheres® Microsphere transcatheter-arterial chemoembolization versus conventional TACE in treating renal angiomyolipoma patients. Journal of Cancer Research and Therapeutics 2023; 19(4): 933 doi: 10.4103/jcrt.jcrt_2135_22
|
16 |
Z. Cui, P.A. Shukla, P. Habibollahi, H.S. Park, A. Fischman, M.K. Kolber. A systematic review of automated feeder detection software for locoregional treatment of hepatic tumors. Diagnostic and Interventional Imaging 2020; 101(7-8): 439 doi: 10.1016/j.diii.2020.01.011
|
17 |
Zhiyi Peng, Guohong Cao, Qinming Hou, Ling Li, Shihong Ying, Junhui Sun, Guanhui Zhou, Jian Zhou, Xin Zhang, Wenbin Ji, Zhihai Yu, Tiefeng Li, Dedong Zhu, Wenhao Hu, Jiansong Ji, Haijun Du, Changsheng Shi, Xiaohua Guo, Jian Fang, Jun Han, Wenjiang Gu, Xiaoxi Xie, Zhichao Sun, Huanhai Xu, Xia Wu, Tingyang Hu, Jing Huang, Hongjie Hu, Jiaping Zheng, Jun Luo, Yutang Chen, Wenqiang Yu, Guoliang Shao. The Comprehensive Analysis of Efficacy and Safety of CalliSpheres® Drug-Eluting Beads Transarterial Chemoembolization in 367 Liver Cancer Patients: A Multiple-Center, Cohort Study. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2020; 28(3): 249 doi: 10.3727/096504019X15766663541105
|
18 |
Xin Zhang, Xiao Lin, Huafeng Qiu, Zhiyi Peng. An investigation of efficacy, safety, and prognostic factors of drug‐eluting beads‐transarterial chemoembolization operation with CalliSpheres® Microspheres in treating Chinese hepatocellular carcinoma patients. Journal of Clinical Laboratory Analysis 2019; 33(8) doi: 10.1002/jcla.22975
|
19 |
Yaohong Liu, Wensou Huang, Mingji He, Hui Lian, Yongjian Guo, Jingjun Huang, Jingwen Zhou, Kangshun Zhu. Efficacy and Safety of CalliSpheres® Drug-Eluting Beads Transarterial Chemoembolization in Barcelona Clinic Liver Cancer Stage C Patients. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2019; 27(5): 565 doi: 10.3727/096504018X15313896322888
|
20 |
Peng Chen, Peng Yuan, Bo Chen, Jingchang Sun, Hang Shen, Yeben Qian. Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2017; 41(1): 75 doi: 10.1016/j.clinre.2016.05.013
|
21 |
Pierpaolo Biondetti, Carolina Lanza, Serena Carriero, Francesca Arrigoni, Margherita Bevilacqua, Aurora Ruffino, Sonia Triggiani, Adriana Sorce, Andrea Coppola, Anna Maria Ierardi, Massimo Venturini, Giuseppe Guzzardi, Gianpaolo Carrafiello. Efficacy and Safety of Transarterial Chemoembolization with DC Beads LUMI in the Treatment of HCC: Experience from a Tertiary Centre. Technology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231184840
|
22 |
Konstantinos Katsanos, Panagiotis Kitrou, Stavros Spiliopoulos, Ioannis Maroulis, Theodore Petsas, Dimitris Karnabatidis, Sheng-Nan Lu. Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials. PLOS ONE 2017; 12(9): e0184597 doi: 10.1371/journal.pone.0184597
|
23 |
Mick. M. Welling, Nikolas Duszenko, Maarten P. van Meerbeek, Tom J. M. Molenaar, Tessa Buckle, Fijs W. B. van Leeuwen, Daphne D. D. Rietbergen. Microspheres as a Carrier System for Therapeutic Embolization Procedures: Achievements and Advances. Journal of Clinical Medicine 2023; 12(3): 918 doi: 10.3390/jcm12030918
|
24 |
Minpeng Li, Jun He, Meng Pan, Yuan Yu, Zhuang Pan, Bin Xu, Jiye Zhu. Iodine-125 implantation plus transarterial chemoembolization for the treatment of hepatocellular carcinoma of 3–5cm: A propensity score matching study. Digestive and Liver Disease 2016; 48(9): 1082 doi: 10.1016/j.dld.2016.06.007
|
25 |
Dawei Wang, Qirun Wu, Rui Guo, Chennan Lu, Meng Niu, Wei Rao. Magnetic liquid metal loaded nano-in-micro spheres as fully flexible theranostic agents for SMART embolization. Nanoscale 2021; 13(19): 8817 doi: 10.1039/D1NR01268A
|
26 |
Yanqiao Ren, Xiangjun Dong, Lei Chen, Tao Sun, Osamah Alwalid, Xuefeng Kan, Yangbo Su, Bin Xiong, Huimin Liang, Chuansheng Zheng, Ping Han. Combined Ultrasound and CT-Guided Iodine-125 Seeds Implantation for Treatment of Residual Hepatocellular Carcinoma Located at Complex Sites After Transcatheter Arterial Chemoembolization. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.582544
|
27 |
Aman Saini, Alex Wallace, Sadeer Alzubaidi, M. Grace Knuttinen, Sailendra Naidu, Rahul Sheth, Hassan Albadawi, Rahmi Oklu. History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma. Journal of Clinical Medicine 2019; 8(1): 55 doi: 10.3390/jcm8010055
|